Loren Data's SAM Daily™

FBO DAILY ISSUE OF OCTOBER 25, 2012 FBO #3988
SOLICITATION NOTICE

65 -- RADIOPHARMACEUTICAL

Notice Date

10/23/2012
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

325412 — Pharmaceutical Preparation Manufacturing
 

Contracting Office

Department of the Army, U.S. Army Medical Command, MEDCOM, North Atlantic Regional Contracting Office, ATTN: MCAA NA Bldg T20, 6900 Georgia Avenue NW, Washington, District of Columbia, 20307-5000
 

ZIP Code

20307-5000
 

Solicitation Number

W91YTZ13T0083FORTBELVOIRBPA
 

Archive Date

11/9/2012
 

Point of Contact

Ann Renee Branham, Phone: 703-806-0214
 

E-Mail Address

ann.r.branham@us.army.mil
(ann.r.branham@us.army.mil)
 

Small Business Set-Aside

N/A
 

Description

North Atlantic Regional Contracting Office, Fort Belvoir Cell, Fort Belvoir, VA. 22060 Blanket Purchase Agreement (BPA) for Radiopharmaceutical Doses Will be Issued For a Period of Five (5) Years. This document is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a written solicitation will not be issued. The proposed contract action is for supplies or services for which the Government intends to solicit competitive offers. Interested persons may submit offers, and all eligible offers received prior to the date listed in FBO will be considered by the Government. The NAICS code is 325412 and the size standard is 750 Employees. Only emailed requests received directly from the requester are acceptable. Offers are due electronically to ann.r.branham@us.army.mil no later than the date listed on FBO. Only electronic offers will be considered. All questions concerning this solicitation must be received by October 24, 2012, 11:00 AM EST. Please submit a separate price sheet listing the quantity, unit price and extended amount for each radiopharmaceutical dose listed below. Offerors must provide pricing for normal and expedited orders for each Radiopharmaceutical Dose identified: Item No. Description Total Cost 1. Radiopharmaceuticals used for clinical nuclear medicine imaging and therapies. Period of Performance: Base Ordering Period: November 1, 2012 - September 30, 2013. ITEMS CONSIST OF THE BELOW PER EACH YEAR IN QUANTITY DETERMINED BY THE REQUIRING CUSTOMER PER EACH YEAR: (1) CIS-MDP, 5 VIAL KIT (SOLD AS EACH) (2) CIS-MDP, 30 VIAL KIT (NOT SOLD AS EACH) (3) CIS-Pyro, 5 VIAL KIT (SOLD AS EACH) (4) CIS-Pyro, 30 VIAL KIT (NOT SOLD AS EACH) (5) Sulfer Colloid 5 VIAL KIT (SOLD AS EACH) (6) Drax DTPA, 30 VIAL KIT (SOLD AS EACH) (7) Hepatolite, 5 VIAL KIT (SOLD AS EACH) (8) Hepatolite, 30 VIAL KIT (NOT SOLD AS KIT) (9) Mebrofenin, 5 VIAL KIT (SOLD AS EACH) (10) Mebrofenin, 30 VIAL KIT (NOT SOLD AS EACH) (11) Sestamibi, 5 VIAL KIT (SOLD AS EACH) (12) Sestamibi, 30 VIAL KIT (NOT SOLD AS EACH) 2. Radiopharmaceuticals used for clinical nuclear medicine imaging and therapies. Period of Performance: Ordering Period Twor: October 1, 2013 - September 30, 2014. ITEMS CONSIST OF THE BELOW PER EACH YEAR IN QUANTITY DETERMINED BY THE REQUIRING CUSTOMER PER EACH YEAR: (1) CIS-MDP, 5 VIAL KIT (SOLD AS EACH) (2) CIS-MDP, 30 VIAL KIT (NOT SOLD AS EACH) (3) CIS-Pyro, 5 VIAL KIT (SOLD AS EACH) (4) CIS-Pyro, 30 VIAL KIT (NOT SOLD AS EACH) (5) Sulfer Colloid 5 VIAL KIT (SOLD AS EACH) (6) Drax DTPA, 30 VIAL KIT (SOLD AS EACH) (7) Hepatolite, 5 VIAL KIT (SOLD AS EACH) (8) Hepatolite, 30 VIAL KIT (NOT SOLD AS KIT) (9) Mebrofenin, 5 VIAL KIT (SOLD AS EACH) (10) Mebrofenin, 30 VIAL KIT (NOT SOLD AS EACH) (11) Sestamibi, 5 VIAL KIT (SOLD AS EACH) (12) Sestamibi, 30 VIAL KIT (NOT SOLD AS EACH) 3. Radiopharmaceuticals used for clinical nuclear medicine imaging and therapies. Period of Performance: Ordering Period Three: November 1, 2014 - September 30, 2015. ITEMS CONSIST OF THE BELOW PER EACH YEAR IN QUANTITY DETERMINED BY THE REQUIRING CUSTOMER PER EACH YEAR: (1) CIS-MDP, 5 VIAL KIT (SOLD AS EACH) (2) CIS-MDP, 30 VIAL KIT (NOT SOLD AS EACH) (3) CIS-Pyro, 5 VIAL KIT (SOLD AS EACH) (4) CIS-Pyro, 30 VIAL KIT (NOT SOLD AS EACH) (5) Sulfer Colloid 5 VIAL KIT (SOLD AS EACH) (6) Drax DTPA, 30 VIAL KIT (SOLD AS EACH) (7) Hepatolite, 5 VIAL KIT (SOLD AS EACH) (8) Hepatolite, 30 VIAL KIT (NOT SOLD AS KIT) (9) Mebrofenin, 5 VIAL KIT (SOLD AS EACH) (10) Mebrofenin, 30 VIAL KIT (NOT SOLD AS EACH) (11) Sestamibi, 5 VIAL KIT (SOLD AS EACH) (12) Sestamibi, 30 VIAL KIT (NOT SOLD AS EACH) 4. Radiopharmaceuticals used for clinical nuclear medicine imaging and therapies. Period of Performance: Ordering Period Four: November 1, 2015 - September 30, 2016. ITEMS CONSIST OF THE BELOW PER EACH YEAR IN QUANTITY DETERMINED BY THE REQUIRING CUSTOMER PER EACH YEAR: (1) CIS-MDP, 5 VIAL KIT (SOLD AS EACH) (2) CIS-MDP, 30 VIAL KIT (NOT SOLD AS EACH) (3) CIS-Pyro, 5 VIAL KIT (SOLD AS EACH) (4) CIS-Pyro, 30 VIAL KIT (NOT SOLD AS EACH) (5) Sulfer Colloid 5 VIAL KIT (SOLD AS EACH) (6) Drax DTPA, 30 VIAL KIT (SOLD AS EACH) (7) Hepatolite, 5 VIAL KIT (SOLD AS EACH) (8) Hepatolite, 30 VIAL KIT (NOT SOLD AS KIT) (9) Mebrofenin, 5 VIAL KIT (SOLD AS EACH) (10) Mebrofenin, 30 VIAL KIT (NOT SOLD AS EACH) (11) Sestamibi, 5 VIAL KIT (SOLD AS EACH) (12) Sestamibi, 30 VIAL KIT (NOT SOLD AS EACH) 5. Radiopharmaceuticals used for clinical nuclear medicine imaging and therapies. Period of Performance: Ordering Period Five: November 1, 2016 - September 30, 2017. ITEMS CONSIST OF THE BELOW PER EACH YEAR IN QUANTITY DETERMINED BY THE REQUIRING CUSTOMER PER EACH YEAR: (1) CIS-MDP, 5 VIAL KIT (SOLD AS EACH) (2) CIS-MDP, 30 VIAL KIT (NOT SOLD AS EACH) (3) CIS-Pyro, 5 VIAL KIT (SOLD AS EACH) (4) CIS-Pyro, 30 VIAL KIT (NOT SOLD AS EACH) (5) Sulfer Colloid 5 VIAL KIT (SOLD AS EACH) (6) Drax DTPA, 30 VIAL KIT (SOLD AS EACH) (7) Hepatolite, 5 VIAL KIT (SOLD AS EACH) (8) Hepatolite, 30 VIAL KIT (NOT SOLD AS KIT) (9) Mebrofenin, 5 VIAL KIT (SOLD AS EACH) (10) Mebrofenin, 30 VIAL KIT (NOT SOLD AS EACH) (11) Sestamibi, 5 VIAL KIT (SOLD AS EACH) (12) Sestamibi, 30 VIAL KIT (NOT SOLD AS EACH) Offerors will be evaluated to the extent they can provide radiopharmaceutical doses that meet the specifications listed. The Government intends to make one (1) award from this RFQ. The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s). A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. The Contracting Officer will evaluate proposals on the basis of information furnished by the offeror or identified in the offer and reasonably available to the Contracting Officer. The Contracting Officer is not responsible for locating or obtaining any information not identified in the offer. INSTRUCTIONS TO OFFERORS As a minimum, offers must include- 1. Offerors must return provision 52.212-3 with their proposal. Offerors may either (1) complete all relevant portions of the provision or (2) complete paragraph (b) of the provision and indicate that it has completed official representations and certifications online at https://www.sam.gov/portal/public/SAM. 2. Contact information, Name, Phone Number, Fax Number and email address 3. Mailing address and Remit to address, if different than mailing address 4. Acknowledgment of Solicitation Amendments 5. Offeror's Federal Tax ID Number; 6. Offeror's DUNS number 7. Equipment Place of Manufacture (include US city, state and ZIP+4; or foreign country) 8. Offeror must provide copies of licenses and certifications SOLICITATION PROVISIONS/CONTRACT CLAUSES: FAR 52.212-1 Instructions to Offerors - Commercial Items (Feb 2012). FAR 52.212-3 Offeror Representations and Certifications -- Commercial Items (Apr 2012): Offerors must include a completed copy of the provision with its offer or fill out online representations and certifications at https://orca.bpn.gov/. FAR 52.212-4 Contract Terms and Conditions -- Commercial Items (Feb 2012). FAR 52.212-5 Contract Terms and Conditions Required To Implement Statutes Or Executive Orders -- Commercial Items (Aug 2012) For the purposes of this clause items (b) 1,4,6,10,14,23,26,27,28,29,30,31,32,33,34,41,42, and 48 are considered checked and apply. FAR 52.232-38 Submission of Electronic Funds Transfer Information with Offer (May 1999) FAR 52.252-1 - Solicitation Provisions Incorporated by Reference (Feb 1998); for the purpose of this provision, the fill-in's are http://farsite.hill.af.mil/farsites.html and http://farsite.hill.af.mil/vfvara.HTM respectively. FAR 52.252-2 - Clauses Incorporated by Reference (Feb 1998); for the purpose of this clause, the fill-in's are http://farsite.hill.af.mil/farsites.html and http://farsite.hill.af.mil/vfvara.HTM respectively. FAR 52.223-3 Hazardous Material Identification and Material Safety Data-Alternate I (Jul 1995) FAR 52.223-7 Notice of Radioactive Materials (Jan 1997) For the purpose of this clause, the fill-in is "7 Days." FAR 52.232-18 Availability of Funds (Apr 1984) FAR 52.217-5 Evaluation of Options (Jul 1990) Except when it is determined in accordance with FAR 17.206(b) not to be in the Government's best interests, the Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. Evaluation of options will not obligate the Government to exercise the option(s). FAR 52.217-9 Option to Extend the Term of the Contract (Mar 2000) (a) The Government may extend the term of this contract by written notice to the Contractor within 30 day provided that the Government gives the Contractor a preliminary written notice of its intent to extend at least 60 days before the contract expires. The preliminary notice does not commit the Government to an extension. (b) If the Government exercises this option, the extended contract shall be considered to include this option clause. (c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed five (5) years.
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/spg/USA/MEDCOM/DADA15/W91YTZ13T0083FORTBELVOIRBPA/listing.html)
 

Place of Performance

Address: FORT BELVOIR COMMUNITY HOSPITAL, FORT BELVOIR, 1414 DEWITT LOOP FORT BELVOIR, FAIRFAX COUNTY, Fort Belvoir, Virginia, 22060, United States

Zip Code: 22060
 

Record

SN02918228-W 20121025/121023234255-bba1c4cb75b5658947da2e52f3bd4550 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |